US Stock MarketDetailed Quotes

Sionna Therapeutics (SION)

Watchlist
  • 38.850
  • -2.330-5.66%
Close Jan 15 16:00 ET
  • 38.800
  • -0.050-0.13%
Post 19:15 ET
1.73BMarket Cap-24.43P/E (TTM)

Sionna Therapeutics (SION) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
13.89%-15.23M
-78.94%-18.15M
-23.63%-16.29M
-20.80%-52.79M
-58.09%-11.78M
-17.69M
-10.15M
-13.18M
-21.16%-43.7M
-7.45M
Net income from continuing operations
20.29%-20.28M
-111.27%-18.07M
-39.12%-16.48M
-30.52%-61.69M
-33.45%-15.85M
---25.44M
---8.55M
---11.85M
-17.45%-47.26M
---11.88M
Depreciation and amortization
11.83%189K
-11.45%147K
-4.22%159K
14.58%668K
3.73%167K
--169K
--166K
--166K
377.87%583K
--161K
Other non cash items
-94.63%490K
0.00%490K
-0.20%491K
385.39%10.6M
-21.85%490K
--9.13M
--490K
--492K
--2.18M
--627K
Change In working capital
220.80%1.9M
-13.18%-2.4M
26.53%-1.85M
-292.72%-3.08M
0.55%3.14M
---1.57M
---2.12M
---2.52M
-128.33%-783K
--3.12M
-Change in prepaid assets
125.04%177K
29.07%-161K
55.03%-559K
-928.83%-2.76M
-227.29%-583K
---707K
---227K
---1.24M
144.22%333K
--458K
-Change in payables and accrued expense
715.03%2.25M
-22.72%-1.71M
19.54%-766K
263.88%1.55M
52.44%4.26M
---366K
---1.39M
---952K
-126.84%-944K
--2.79M
-Change in other current assets
--0
--0
--0
--35K
---9K
--15K
--14K
--15K
--0
--0
-Change in other current liabilities
-2.92%-529K
-2.92%-528K
-54.39%-528K
-1,002.91%-1.9M
-303.05%-528K
---514K
---513K
---342K
---172K
---131K
Cash from discontinued investing activities
Operating cash flow
13.89%-15.23M
-78.94%-18.15M
-23.63%-16.29M
-20.80%-52.79M
-58.09%-11.78M
---17.69M
---10.15M
---13.18M
-21.16%-43.7M
---7.45M
Investing cash flow
Cash flow from continuing investing activities
121.99%23.1M
18.78%-23.25M
-13.93%-141.19M
-564.00%-126.91M
113.64%15.23M
10.41M
-28.62M
-123.93M
193.47%27.35M
7.13M
Net PPE purchase and sale
---87K
--0
---86K
97.58%-27K
77.87%-27K
--0
--0
--0
40.45%-1.12M
---122K
Net investment purchase and sale
122.82%23.19M
18.78%-23.25M
-13.86%-141.11M
-545.71%-126.89M
110.41%15.26M
--10.41M
---28.62M
---123.93M
203.94%28.47M
--7.25M
Cash from discontinued investing activities
Investing cash flow
121.99%23.1M
18.78%-23.25M
-13.93%-141.19M
-564.00%-126.91M
113.64%15.23M
--10.41M
---28.62M
---123.93M
193.47%27.35M
--7.13M
Financing cash flow
Cash flow from continuing financing activities
298.19%1.97M
-921.05%-312K
11.61%202.39M
577,212.90%178.97M
-1.41M
-996K
38K
181.33M
-99.97%31K
0
Net common stock issuance
--0
---318K
--202.39M
----
----
--0
--0
--0
----
----
Net preferred stock issuance
--0
--0
--0
--181.33M
--0
--0
--0
--181.33M
--0
--0
Proceeds from stock option exercised by employees
2,604.11%1.97M
-84.21%6K
--0
354.84%141K
--25K
--73K
--38K
--5K
-51.56%31K
--0
Net other financing activities
----
----
----
---2.5M
---1.43M
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
298.19%1.97M
-921.05%-312K
11.61%202.39M
577,212.90%178.97M
---1.41M
---996K
--38K
--181.33M
-99.97%31K
--0
Net cash flow
Beginning cash position
-6.76%41.95M
-0.07%83.66M
-1.86%38.75M
-29.24%39.48M
-7.78%36.71M
--44.99M
--83.71M
--39.48M
443.06%55.8M
--39.81M
Current changes in cash
218.98%9.85M
-7.70%-41.71M
1.53%44.91M
95.51%-733K
729.32%2.04M
---8.28M
---38.73M
--44.23M
-135.84%-16.32M
---324K
End cash Position
41.08%51.79M
-6.76%41.95M
-0.07%83.66M
-1.86%38.75M
-1.86%38.75M
--36.71M
--44.99M
--83.71M
-29.24%39.48M
--39.48M
Free cash flow
13.39%-15.32M
-78.94%-18.15M
-24.28%-16.37M
-17.85%-52.81M
-55.90%-11.81M
---17.69M
---10.15M
---13.18M
-18.11%-44.82M
---7.57M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 13.89%-15.23M-78.94%-18.15M-23.63%-16.29M-20.80%-52.79M-58.09%-11.78M-17.69M-10.15M-13.18M-21.16%-43.7M-7.45M
Net income from continuing operations 20.29%-20.28M-111.27%-18.07M-39.12%-16.48M-30.52%-61.69M-33.45%-15.85M---25.44M---8.55M---11.85M-17.45%-47.26M---11.88M
Depreciation and amortization 11.83%189K-11.45%147K-4.22%159K14.58%668K3.73%167K--169K--166K--166K377.87%583K--161K
Other non cash items -94.63%490K0.00%490K-0.20%491K385.39%10.6M-21.85%490K--9.13M--490K--492K--2.18M--627K
Change In working capital 220.80%1.9M-13.18%-2.4M26.53%-1.85M-292.72%-3.08M0.55%3.14M---1.57M---2.12M---2.52M-128.33%-783K--3.12M
-Change in prepaid assets 125.04%177K29.07%-161K55.03%-559K-928.83%-2.76M-227.29%-583K---707K---227K---1.24M144.22%333K--458K
-Change in payables and accrued expense 715.03%2.25M-22.72%-1.71M19.54%-766K263.88%1.55M52.44%4.26M---366K---1.39M---952K-126.84%-944K--2.79M
-Change in other current assets --0--0--0--35K---9K--15K--14K--15K--0--0
-Change in other current liabilities -2.92%-529K-2.92%-528K-54.39%-528K-1,002.91%-1.9M-303.05%-528K---514K---513K---342K---172K---131K
Cash from discontinued investing activities
Operating cash flow 13.89%-15.23M-78.94%-18.15M-23.63%-16.29M-20.80%-52.79M-58.09%-11.78M---17.69M---10.15M---13.18M-21.16%-43.7M---7.45M
Investing cash flow
Cash flow from continuing investing activities 121.99%23.1M18.78%-23.25M-13.93%-141.19M-564.00%-126.91M113.64%15.23M10.41M-28.62M-123.93M193.47%27.35M7.13M
Net PPE purchase and sale ---87K--0---86K97.58%-27K77.87%-27K--0--0--040.45%-1.12M---122K
Net investment purchase and sale 122.82%23.19M18.78%-23.25M-13.86%-141.11M-545.71%-126.89M110.41%15.26M--10.41M---28.62M---123.93M203.94%28.47M--7.25M
Cash from discontinued investing activities
Investing cash flow 121.99%23.1M18.78%-23.25M-13.93%-141.19M-564.00%-126.91M113.64%15.23M--10.41M---28.62M---123.93M193.47%27.35M--7.13M
Financing cash flow
Cash flow from continuing financing activities 298.19%1.97M-921.05%-312K11.61%202.39M577,212.90%178.97M-1.41M-996K38K181.33M-99.97%31K0
Net common stock issuance --0---318K--202.39M----------0--0--0--------
Net preferred stock issuance --0--0--0--181.33M--0--0--0--181.33M--0--0
Proceeds from stock option exercised by employees 2,604.11%1.97M-84.21%6K--0354.84%141K--25K--73K--38K--5K-51.56%31K--0
Net other financing activities ---------------2.5M---1.43M--------------------
Cash from discontinued financing activities
Financing cash flow 298.19%1.97M-921.05%-312K11.61%202.39M577,212.90%178.97M---1.41M---996K--38K--181.33M-99.97%31K--0
Net cash flow
Beginning cash position -6.76%41.95M-0.07%83.66M-1.86%38.75M-29.24%39.48M-7.78%36.71M--44.99M--83.71M--39.48M443.06%55.8M--39.81M
Current changes in cash 218.98%9.85M-7.70%-41.71M1.53%44.91M95.51%-733K729.32%2.04M---8.28M---38.73M--44.23M-135.84%-16.32M---324K
End cash Position 41.08%51.79M-6.76%41.95M-0.07%83.66M-1.86%38.75M-1.86%38.75M--36.71M--44.99M--83.71M-29.24%39.48M--39.48M
Free cash flow 13.39%-15.32M-78.94%-18.15M-24.28%-16.37M-17.85%-52.81M-55.90%-11.81M---17.69M---10.15M---13.18M-18.11%-44.82M---7.57M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More